PCAC member Elizabeth Rebello, a professor in the Department of Anesthesiology and Perioperative Medicine at the University of Texas MD Anderson Cancer Center, cited the "lack of efficacy data and randomized controlled trials" as her basis for her no vote
There are at least two processes of aminoglycoside-induced cell death that depend on both the particular aminoglycoside and exposure time (Coffin et al., 2012)
Most patients are diagnosed in the middle to late stages of the illness, when irreversible brain damage has already occurred and interventions to prevent the disease are less likely to be successful (Nation et al., 2019)
Its cytoprotective mechanisms in this context are multifaceted: it bypasses the prostaglandin pathway, maintains endothelial integrity to ensure blood flow to the mucosa, and directly stimulates the cellular processes required for repair
It works especially well when combined with GLP-1 agonists like semaglutide, delivering greater results than either alone